138 related articles for article (PubMed ID: 12778013)
21. Surgery of skull base tumors.
DeMonte F
Curr Opin Oncol; 1995 May; 7(3):201-6. PubMed ID: 7654820
[TBL] [Abstract][Full Text] [Related]
22. Borderland.
McLennan JE
Med Health R I; 2002 May; 85(5):163-4. PubMed ID: 12048751
[No Abstract] [Full Text] [Related]
23. Prognostic Factors for Survival Outcome of High-Grade Multicentric Glioma.
Wang T; Niu X; Gao T; Zhao L; Li J; Gan Y; Liu Y; Mao Q
World Neurosurg; 2018 Apr; 112():e269-e277. PubMed ID: 29337167
[TBL] [Abstract][Full Text] [Related]
24. Genetics, prognosis and therapy of central nervous system tumors.
Watkins D; Rouleau GA
Cancer Detect Prev; 1994; 18(2):139-44. PubMed ID: 8025896
[TBL] [Abstract][Full Text] [Related]
25. Encouraging early clinical outcomes with helical tomotherapy-based image-guided intensity-modulated radiation therapy for residual, recurrent, and/or progressive benign/low-grade intracranial tumors: a comprehensive evaluation.
Gupta T; Wadasadawala T; Master Z; Phurailatpam R; Pai-Shetty R; Jalali R
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):756-64. PubMed ID: 21345610
[TBL] [Abstract][Full Text] [Related]
26. Low-grade gliomas: management issues.
Duran I; Raizer JJ
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S15-21. PubMed ID: 18076313
[TBL] [Abstract][Full Text] [Related]
27. Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?
Reznik E; Smith AW; Taube S; Mann J; Yondorf MZ; Parashar B; Wernicke AG
Am J Clin Oncol; 2018 Feb; 41(2):197-212. PubMed ID: 28906259
[TBL] [Abstract][Full Text] [Related]
28. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
[TBL] [Abstract][Full Text] [Related]
29. BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial.
Burri SH; Prabhu RS; Sumrall AL; Brick W; Blaker BD; Heideman BE; Boltes P; Kelly R; Symanowski JT; Wiggins WF; Ashby L; Norton HJ; Judy K; Asher AL
J Neurooncol; 2015 Jun; 123(2):259-66. PubMed ID: 25947286
[TBL] [Abstract][Full Text] [Related]
30. The inherent invasiveness of cerebral gliomas: implications for clinical management.
Laws ER; Shaffrey ME
Int J Dev Neurosci; 1999; 17(5-6):413-20. PubMed ID: 10571404
[No Abstract] [Full Text] [Related]
31. Treatment of malignant brain tumors.
Takakura K; Kubo O
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():449-53. PubMed ID: 10895194
[No Abstract] [Full Text] [Related]
32. [Pattern of care of high-grade gliomas].
Laigle-Donadey F; Sanson M
Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
[TBL] [Abstract][Full Text] [Related]
33. Olfactory groove meningioma.
Adappa ND; Lee JY; Chiu AG; Palmer JN
Otolaryngol Clin North Am; 2011 Aug; 44(4):965-80, ix. PubMed ID: 21819883
[TBL] [Abstract][Full Text] [Related]
34. Radiosurgical options in neuro-oncology: a review on current tenets and future opportunities. Part I: therapeutic strategies.
Ganau M; Foroni RI; Gerosa M; Zivelonghi E; Longhi M; Nicolato A
Tumori; 2014; 100(4):459-65. PubMed ID: 25296597
[TBL] [Abstract][Full Text] [Related]
35. Malignant astrocytic gliomas in children.
Marchese MJ; Chang CH
Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
[TBL] [Abstract][Full Text] [Related]
36. [HIT-GBM: multicenter study of treatment of children with malignant glioma].
Wolff JE; Boos J; Kühl J
Klin Padiatr; 1996; 208(4):193-6. PubMed ID: 8926684
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up results of 175 patients with malignant glioma.
Kreth FW; Warnke PC; Ostertag CB
Acta Neurochir (Wien); 1994; 131(1-2):164-6. PubMed ID: 7535970
[No Abstract] [Full Text] [Related]
38. Current treatment options for meningioma.
Apra C; Peyre M; Kalamarides M
Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
[TBL] [Abstract][Full Text] [Related]
39. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Jakacki RI; Cohen KJ; Buxton A; Krailo MD; Burger PC; Rosenblum MK; Brat DJ; Hamilton RL; Eckel SP; Zhou T; Lavey RS; Pollack IF
Neuro Oncol; 2016 Oct; 18(10):1442-50. PubMed ID: 27006176
[TBL] [Abstract][Full Text] [Related]
40. Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial.
Cabrera AR; Cuneo KC; Desjardins A; Sampson JH; McSherry F; Herndon JE; Peters KB; Allen K; Hoang JK; Chang Z; Craciunescu O; Vredenburgh JJ; Friedman HS; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):873-9. PubMed ID: 23725997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
